Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial.

Abstract

RESULTS

After 12 months, 43 participants (15%) regretted their treatment choice and 105 participants (36%) were dissatisfied with the information that was received at the time of decision-making, regardless of being exposed to the DA. Anxious and depressive symptoms at follow-up were associated with regret and information dissatisfaction.

CONCLUSION

No long-term benefical effects emerged from DA usage compared to patients who underwent standard counseling.

OBJECTIVE

To investigate the effect of including an online decision aid (DA) during prostate cancer treatment counseling on decisional regret and information satisfaction in a one-year follow-up.

PRACTICE IMPLICATIONS

During PCa treatment counseling, healthcare providers should be aware of anxious and depressive symptoms.

METHODS

Within a cluster RCT, 18 Dutch hospitals were randomized to DA counseling or care-as-usual, patients (n = 382) initially completed questionnaires directly after treatment decision making. Six and twelve months later regret (Decisional Regret Scale) and information satisfaction (SCIP-B) were assessed. Anxious and depressive symptoms (HADS) was included as possible covariate.

More about this publication

Patient education and counseling
  • Volume 102
  • Issue nr. 3
  • Pages 424-428
  • Publication date 01-03-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.